|
ZNHIT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.66133814775094E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.21842593978772E-12 |
| Normal-vs-Stage2 |
1.108400E-02 |
| Normal-vs-Stage3 |
3.337900E-03 |
| Normal-vs-Stage4 |
3.430200E-02 |
| Stage1-vs-Stage2 |
6.268800E-01 |
| Stage1-vs-Stage3 |
4.667800E-02 |
| Stage1-vs-Stage4 |
8.841800E-01 |
| Stage2-vs-Stage3 |
4.150400E-01 |
| Stage2-vs-Stage4 |
6.527200E-01 |
| Stage3-vs-Stage4 |
2.021600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6494583476856E-12 |
| Normal-vs-AfricanAmerican |
4.15520000000003E-05 |
| Normal-vs-Asian |
1.298790E-01 |
| Caucasian-vs-AfricanAmerican |
6.288800E-01 |
| Caucasian-vs-Asian |
6.384000E-01 |
| AfricanAmerican-vs-Asian |
6.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.796780E-03 |
| Male-vs-Female |
4.139900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.102590E-03 |
| Normal-vs-Extreme_Weight |
5.08570963120292E-12 |
| Normal-vs-Obese |
3.8552000000025E-05 |
| Normal-vs-Extreme_Obese |
1.489690E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.383600E-01 |
| Normal_Weight-vs-Obese |
9.639600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.843400E-01 |
| Extreme_Weight-vs-Obese |
2.652600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.280400E-01 |
| Obese-vs-Extreme_Obese |
8.974800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.038500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.27499996618974E-09 |
| Normal-vs-Age(61-80Yrs) |
3.88200582790432E-12 |
| Normal-vs-Age(81-100Yrs) |
6.188300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.027200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.366000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.072400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.202400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.223200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.362600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.047700E-02 |
| Normal-VS-KIRP CIMP |
2.706600E-01 |
| Normal-VS-Unclassified PRCC |
4.116700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.89122067900871E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.008300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.38500000024244E-07 |
| Type2 PRCC-VS-KIRP CIMP |
9.213800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.513400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.883000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.17689999995707E-06 |
| Normal-vs-N1 |
3.507900E-02 |
| Normal-vs-N2 |
3.223400E-01 |
| N0-vs-N1 |
9.417600E-02 |
| N0-vs-N2 |
8.645800E-01 |
| N1-vs-N2 |
4.913200E-01 |
|
|
